Skip to main content
Scour
Discover
Docs
Login
Sign Up
Discover
About
Docs
Changelog
You are offline. Trying to reconnect...
Copied to clipboard
Unable to share or copy to clipboard
Back to article
最新情報 Feed
1w
1 week ago
加齢に伴う視力低下の回復を目指す薬剤をヒトに初投与──長寿スタートアップが発表
(opens in new tab)
Covers
2 stories
See all stories this covers
including
Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
Love
Like
Not for me
Save
|
|
Report
Off Topic
Harmful Content
Low Quality
Spam
Misleading
Duplicate
Wrong Language
Block
Add to your feed
Feeds
Share
Report
Off Topic
Harmful Content
Low Quality
Spam
Misleading
Duplicate
Wrong Language
Block Domain
Covers 2 related stories
WIRED
·
1w
1 week ago
Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
Love
Like
Not for me
Save
Add to your feed
Feeds
Share
Report
Off Topic
Harmful Content
Low Quality
Spam
Misleading
Duplicate
Wrong Language
Block Domain
Actions for Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
lifebiosciences.com
·
1w
1 week ago
Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies
Discussed on
Hacker News
Love
Like
Not for me
Save
Add to your feed
Feeds
Share
Report
Off Topic
Harmful Content
Low Quality
Spam
Misleading
Duplicate
Wrong Language
Block Domain
Actions for Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies
Keyboard Shortcuts
Navigation
Next / previous post
j
/
k
Open post
o
or
Enter
Preview post
v
Post Actions
Love post
a
Like post
l
Dislike post
d
Undo reaction
u
Save / unsave
s
Recommendations
Add interest / feed
Enter
Not interested
x
Go to
Home
g
h
Interests
g
i
Feeds
g
f
Likes
g
l
History
g
y
Changelog
g
c
Settings
g
s
Discover
g
b
Search
/
Pagination
Next page
n
Previous page
p
General
Show this help
?
Submit feedback
!
Close modal / unfocus
Esc
Press
?
anytime to show this help
Like
Save
Not for me
Report